One more comment on Jupiter - consistent with my belief that statins act at least as much through CRP related pathways as LDL I predict that the HR will be equal to or better than for any of the LDL based trials of statins at moderate doses (Jupiter did not use the highest dose of Crestor). I.e. a reduction in events of more than 30%.
Market Data 
Markets 
AI
